Related Experiment Video
Updated: May 10, 2026
08:35
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Expanding the indication spectrum: renal denervation in diabetes
Felix Mahfoud1, Sebastian Ewen, Christian Ukena
1Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. felix.mahfoud@uks.eu
Summary
Catheter-based renal denervation (RDN) may improve glucose control in patients with resistant hypertension. This approach targets renal sympathetic nerves, offering a potential new therapy for metabolic syndrome and diabetes.
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Interventional Cardiology
Background:
- Resistant hypertension is linked to increased sympathetic nerve activity.
- Sympathetic overactivity contributes to cardiovascular diseases like diabetes and metabolic syndrome.
- Emerging evidence suggests renal denervation (RDN) may impact glucose metabolism.
Purpose of the Study:
- To review the potential of renal sympathetic nerve modulation for improving glycemic control.
- To explore RDN as a therapeutic strategy in patients with resistant hypertension and metabolic derangements.
Main Methods:
- Review of pilot studies and case reports on RDN in resistant hypertension.
- Analysis of the role of renal sympathetic nerves in cardiovascular and metabolic pathophysiology.
Main Results:
- Catheter-based RDN demonstrates potential for reducing blood pressure and sympathetic activity.
- Preliminary findings indicate beneficial effects of RDN on glucose metabolism in select patients.
- Targeting renal sympathetic nerves is a novel therapeutic avenue.
Conclusions:
- Renal denervation presents a promising therapeutic option for managing resistant hypertension.
- RDN may offer a new strategy to improve glycemic control in patients with comorbid diabetes or metabolic syndrome.
- Further research is warranted to establish RDN's efficacy in metabolic regulation.
Related Concept Videos
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...